Figure 1From: Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients Percentage of patients responding to pantoprazole 40Â mg once daily at Week 4 and Week 8 of treatment. A comparison of Asian populations (combined: Hong Kong, Korea, Malaysia, Singapore and Taiwan) with the rest of the world.Back to article page